Review: interferon and nucleoside/tide analogues reduce risk of hepato-cellular cancer in chronic hepatitis B
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Source of funding: not stated.